Journal article
Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone Metastasis
Renal function impairment in lung cancer patients with bone metastases was investigated, as this can limit the application of bisphosphonates representing the gold standard in the management of such cases. Clinicopathological data of 570 lung cancer patients were retrospectively analysed for changes in renal function parameters.
Co-morbidities included hypertension (50%), COPD (33%) and diabetes mellitus (15%). Statistical analysis was performed with Fisher's exact tests and a Cox proportional hazards model. In patients suffering from hypertension, both median serum creatinine and blood urea nitrogen (BUN) were higher (81.9 versus 75.8 μmol/l, p
| Language: | English |
|---|---|
| Year: | 2017 |
| Pages: | 126-132 |
| ISSN: | 17427835 and 17427843 |
| Types: | Journal article |
| DOI: | 10.1111/bcpt.12876 |
Bisphosphonate treatment Bone metastasis Lung cancer Renal function SDG 3 - Good Health and Well-being
